Clinical Trial Update: Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating irinotecan, 5-fluorouracil, and leucovorin with or without Iressa in metastatic colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Iressa (gefitinib)
• Irinotecan (Camptosar) (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: WITHDRAWN